Company / Capital Expenditures
AYTU BIOPHARMA, INC Capital Expenditures History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$228.0K
FY2025
5-year range
$0 / $2.3M
FY2021-FY2025
Trend
-30.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 9 years, ranging from $0 in FY2022 to $2M in FY2021.
Based on SEC 10-K filings.
$228,000 in FY2025.
Improved from $0 to $228,000 over the past 3 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capital expenditures decreased 30.7% year-over-year.
- Peak capital expenditures was recorded in FY2021.
- Lowest capital expenditures in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $228.0K | -30.7% |
| FY2024 | $329.0K | - |
| FY2023 | - | - |
| FY2022 | $0 | -100.0% |
| FY2021 | $2.3M | - |
| FY2020 | $0 | -100.0% |
| FY2018 | $74.7K | -33.1% |
| FY2017 | $111.6K | -55.9% |
| FY2016 | $252.9K | - |
| FY2015 | $0 | -100.0% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026